Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
John W. Childs currently holds 68,693 shares of Biohaven Pharmaceutical Holding Co Ltd. (BHVN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John W. Childs has been a net seller of BHVN stock. They have purchased $145.7M and sold $247.6M worth of shares.
John W. Childs's most recent insider trade was on Apr 28, 2026, when they sold 68,693 shares at $0.00 per share.
John W. Childs serves as Executive at Biohaven Pharmaceutical Holding Co Ltd. (BHVN). They have executed 71 insider transactions totaling $393.3M over their tenure at the company.
John W. Childs holds the position of Executive at Biohaven Pharmaceutical Holding Co Ltd., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 14 years and currently hold a stake valued at $0.
John W. Childs has shown a selling trading pattern, with $145.7M in total purchases and $247.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by John W. Childs was on Oct 3, 2022, when they sold $449.2M worth of BHVN shares. This transaction involved 3,025,001 shares at $148.50 per share.
John W. Childs currently owns 68,693 shares of Biohaven Pharmaceutical Holding Co Ltd. (BHVN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of John W. Childs's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. John W. Childs has 71 Form 4 filings on record as an insider at Biohaven Pharmaceutical Holding Co Ltd..
Set alerts for John W. Childs and 40,000+ other insiders.